Random

FDA

Kratom

Quick Hits: Opioid and Benzodiazepine, Kratom Ban & More

5 Ideas To Make Prescription Drugs Safer

5 Ideas To Make Prescription Drugs Safer

Suzanne B. Robotti

Sunscreen and Skin Absorption

Sunscreen and Skin Absorption

Suzanne B. Robotti

How To Report Side Effects To The FDA

Drug Interactions/Side Effects

How To Report Side Effects To The FDA

Medshadow Staff

Differin

Healthy Skeptic new

Differin: The Price of Beauty

Suzanne B. Robotti

FDA: Breast Cancer Treatment

Quick Hits: FDA Breast Cancer Treatment & More

Make Your Voice Heard In Patient-Focused Drug Development

Make Your Voice Heard In Patient-Focused Drug Development

Why A Lack of FDA Oversight Can Be Hazardous To Your Skin

Lack of FDA Oversight on Dermatologic Devices is Hazardous

Clinical Trial Research Phase Studies

Clinical Trial Research Phase Studies

Medshadow Staff

What Happens When The FDA Is Addicted To The Drug Industry?

What Happens When The FDA Is Addicted To The Drug Industry?

FDA Advisory Committee and FDA Drug Approval

The Increasing Influence of Big Pharma on FDA Drug Advisory Committees

Warning: Drug Ads May Cause Confusion

Healthy Skeptic 2

Warning: Drug Ads May Cause Confusion

Suzanne B. Robotti

The FDA Has It Wrong on Kratom: How the Herb is Helping People

FDA Cracks Down on Online Sellers of Rx Opioids

FDA Cracks Down on Online Sellers of Rx Opioids

5 New Articles From Our Must-Read List

5 New Articles From Our Must-Read List

Suzanne B. Robotti

Hot Flashes = Hot Market For Noven

Healthy Skeptic new

Hot Flashes = Hot Market For Noven

Suzanne B. Robotti

Open Letter to the FDA: You’re Protecting the Wrong People

Su Calls on the FDA to Release the Names of Drugs Approved Using Fraudulent Data

Open Letter to the FDA: You’re Protecting the Wrong People

Suzanne B. Robotti

FDA Issues High Risk Warning for Transvaginal Mesh

FDA Issues High Risk Warning For Transvaginal Mesh

FDA Approves First Direct-to-Consumer Genetic Risk Tests

Tests and Testing

FDA Approves First Direct-to-Consumer Genetic Risk Tests

FDA Approves OxyContin For Extremely Sick Kids

FDA Issues Related to Healthcare

FDA Approves OxyContin For Extremely Sick Kids

Load More